ABBV-621
Showing 101 - 118 of 118
Ovarian Cancer Trial in United States (SC-003, SC-003 in combination with ABBV-181)
Terminated
- Ovarian Cancer
- SC-003
- SC-003 in combination with ABBV-181
-
Fayetteville, Arkansas
- +15 more
Jan 2, 2019
Head and Neck Squamous Cell Carcinoma, NSCLC, Triple Negative Breast Cancer Trial in Boston, San Antonio, Madrid (ABBV-221)
Terminated
- Head and Neck Squamous Cell Carcinoma
- +4 more
-
Boston, Massachusetts
- +4 more
Mar 28, 2018
Type 2 Diabetes Trial (Interactive Dialogue to Educate and Activate (IDEA), Individual Education (IE))
Completed
- Type 2 Diabetes Mellitus
- Interactive Dialogue to Educate and Activate (IDEA)
- Individual Education (IE)
- (no location specified)
Apr 27, 2017
Rheumatoid Arthritis Trial in Berlin (ABBV-257, Placebo)
Completed
- Rheumatoid Arthritis
- ABBV-257
- Placebo
-
Berlin, GermanySite Reference ID/Investigator# 139394
Mar 1, 2016
Smoking Cessation Trial in Memphis (Counselor-Initiated Tobacco Quit Line, Self-Paced Tobacco Quit Line)
Completed
- Smoking Cessation
- Counselor-Initiated Tobacco Quit Line
- Self-Paced Tobacco Quit Line
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 24, 2014
HeartTrends HRV Algorithm for Detection of Myocardial Ischemia
Unknown status
- Heart Rate Variability Ischemia Detection
-
Rochester, Minnesota
- +1 more
Jul 23, 2014
Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies Trial in United States (ARQ 621)
Completed
- Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies
- ARQ 621
-
Phoenix, Arizona
- +3 more
Oct 17, 2011
Patients With NMDA Biomarker Data Following Cardiac Surgery
Terminated
- Congenital Disorders
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jun 12, 2007